Outcome of the Board Meeting held on September 06, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chandra Bhagat Pharma's board met on September 6, 2025 and approved the Secretarial Audit Report and Board Report for FY ending March 31, 2025. The board fixed September 30, 2025 as the date for the 22nd Annual General Meeting (AGM) to be held at the registered office in Matunga, Mumbai at 4:00 PM. The Register of Members and Share Transfer Books will be closed from September 24 to September 30, 2025, with September 23, 2025 set as the record date. The notice also includes the re-appointment of Mr. Hemant Chandravadan Bhagat (DIN: 00233530), Managing Director, who retires by rotation. The company is listed on the SME platform of BSE and is exempt from providing e-voting facilities.
This is a routine procedural filing with no material impact on shareholders. The director re-appointment of Mr. Hemant Bhagat (holding 26,78,495 equity shares) is standard AGM business. Investors should note the book closure dates (September 24-30, 2025) during which share transfers will not be processed.